Cell line development at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
6 organizations at Cell 2026 present work in cell line development: 3 academic, government and non-profit bodies, 2 suppliers and service providers and 1 drug developer. Between them they bring 14 presentations to the program. Most represented: AstraZeneca (4 on the program), Technical University of Denmark (1 on the program), University of Sheffield (1 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–6 of 6 organizations
| Organization | Cell 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline. | Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing |
Technical University of Denmark Kongens Lyngby, Denmark | |
Danish technical university with research in biotechnology, bioprocess engineering and cell line engineering. | Talk Thu Nov 12 4:55pm–5:20pm Minimised Process Development By Recombinase Based Targeted Insertion For Superfast Clone Development Allowing Prefabricated Manufacturing Process Cell line developmentManufacturing and CMC Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy |
University of Sheffield Sheffield, UK | |
Research university with biopharmaceutical engineering work on cell, vector and media engineering for hard-to-produce biologics. | Panel Thu Nov 12 12:25pm–12:50pm Manufacturing Next-Generation Therapeutic Modalities Manufacturing and CMC Talk Thu Nov 12 2:40pm–3:05pm Cell, Vector And Media Engineering To Facilitate Manufacture Of ‘Difficult-To-Express’ Products Cell line developmentCell culture and upstream processing |
CA CRUK-AstraZeneca Antibody Alliance Laboratory | |
Joint Cancer Research UK and AstraZeneca lab that develops antibodies against cancer targets put forward by academic researchers. | Talk Thu Nov 12 10:15am–10:40am Vector Design As The Strategic Lever In Biologics Development Cell line development |
Beckman Coulter Life Sciences Indianapolis, Indiana | ◇Silver Sponsor |
Makes flow cytometers, cell counters, particle analysers, centrifuges, liquid handlers and genomics tools for research and bioprocess labs. | Talk Thu Nov 12 9:50am–10:15am Choosing the Clone That Scales: Process-Controlled, Fed-Batch Screening of 96 Clones in Parallel with the Cydem VT Automated Clone Screening System Cell line developmentCell culture and upstream processing |
Ingenza Roslin, UK | Presentation & exhibition package |
Contract developer of microbial and mammalian production strains, cell lines and bioprocesses for biologics and industrial products. | Talk Thu Nov 12 3:30pm–3:55pm |
Instantly find 20 buyers in cell line development
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction